Tumour Necrosis Factor Inhibitors and Infection: What Is there to Know for Infectious Diseases Physicians?

At this year's meeting of Digestive Disease Week in Los Angeles, California, it was noted that antitumour necrosis factor (anti-TNF) inhibitors showed further evidence of efficacy in Crohn's disease (1). TNF antagonists have been used increasingly in the treatment of a number of other infl...

Full description

Bibliographic Details
Main Authors: BL Johnston, JM Conly
Format: Article
Language:English
Published: Hindawi Limited 2006-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2006/385789